A Phase II Trial of Ifosfamide and Oral Etoposide For Refractory Ovarian Cancer

Abstracts/Posters/Presentations:

• Montaser Shaheen, John W. McClean, Lawrence H. Einhorn. A Phase II Study of Ifosfamide plus Etoposide in Previously treated Ovarian Cancer, A Hoosier Oncology Group Study GYN98-1. Accepted to the ASCO Annual Meeting May 12-15, 2001, San Francisco, CA

Manuscripts/Articles

• Shaheen M, Stender MJ, McClean JW, Look KY, Einhorn LH. Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer: a Hoosier Oncology Group (HOG) study. Am J Clin Oncol. 2004 Jun;27(3):229-31. See abstract.